FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117764603> ?p ?o ?g. }

• W2117764603 endingPage "5175" @default.
• W2117764603 startingPage "5170" @default.
• W2117764603 abstract "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been introduced as antitumor agents in the treatment of cancers overexpressing the receptor. The treatment has gastrointestinal side effects which may decrease patient compliance and limit the efficacy. Glucagon-like peptide-2 (GLP-2) is an intestinal hormone with potent intestinotrophic properties and therapeutic potential in disorders with compromised intestinal capacity. The growth stimulation is highly specific to the gastrointestinal tract, and no effects are observed elsewhere. The aim of this study was to examine whether the inhibition of the EGFR induces intestinal atrophy and if this can be counteracted by treatment with GLP-2.Mice were treated for 10 days with either gefitinib orally, GLP-2 as injections, or a combination of both. After sacrifice, the weight and length of the segments of the gastrointestinal tract were determined, and histologic sections were analyzed by morphometric methods.A significant atrophy of the small-intestinal wall was observed after treatment with gefitinib because both intestinal weight and morphometrically estimated villus height and cross-sectional area were decreased. The same parameters were increased by GLP-2 treatment alone, and when GLP-2 was combined with the gefitinib treatment, the parameters remained unchanged.Treatment with an EGFR tyrosine kinase inhibitor in mice results in small-intestinal growth inhibition that can be completely prevented by simultaneous treatment with GLP-2. This suggests that the gastrointestinal side effects elicited by treatment with EGFR tyrosine kinase inhibitors can be circumvented by GLP-2 treatment." @default.
• W2117764603 created "2016-06-24" @default.
• W2117764603 creator A5011803647 @default.
• W2117764603 creator A5046035975 @default.
• W2117764603 creator A5047145712 @default.
• W2117764603 creator A5085434984 @default.
• W2117764603 creator A5086797250 @default.
• W2117764603 date "2007-09-01" @default.
• W2117764603 modified "2023-10-15" @default.
• W2117764603 title "The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib" @default.
• W2117764603 cites W1752824908 @default.
• W2117764603 cites W1823570072 @default.
• W2117764603 cites W1960059531 @default.
• W2117764603 cites W1979876446 @default.
• W2117764603 cites W2001237141 @default.
• W2117764603 cites W2001652802 @default.
• W2117764603 cites W2005204942 @default.
• W2117764603 cites W2005325539 @default.
• W2117764603 cites W2006578936 @default.
• W2117764603 cites W2010174111 @default.
• W2117764603 cites W2011642803 @default.
• W2117764603 cites W2013395086 @default.
• W2117764603 cites W2022809181 @default.
• W2117764603 cites W2029154514 @default.
• W2117764603 cites W2040200458 @default.
• W2117764603 cites W2043637331 @default.
• W2117764603 cites W2044619586 @default.
• W2117764603 cites W2046166794 @default.
• W2117764603 cites W2059340162 @default.
• W2117764603 cites W2063223489 @default.
• W2117764603 cites W2064047613 @default.
• W2117764603 cites W2086507251 @default.
• W2117764603 cites W2090245368 @default.
• W2117764603 cites W2093875398 @default.
• W2117764603 cites W2099294050 @default.
• W2117764603 cites W2104431314 @default.
• W2117764603 cites W2111973958 @default.
• W2117764603 cites W2127068727 @default.
• W2117764603 cites W2135148499 @default.
• W2117764603 cites W2139916512 @default.
• W2117764603 cites W2146404049 @default.
• W2117764603 cites W2147037760 @default.
• W2117764603 cites W2153534791 @default.
• W2117764603 cites W2157825476 @default.
• W2117764603 cites W2158564298 @default.
• W2117764603 cites W2159328216 @default.
• W2117764603 cites W2161966085 @default.
• W2117764603 cites W2167313634 @default.
• W2117764603 cites W2167368130 @default.
• W2117764603 cites W2169332099 @default.
• W2117764603 cites W2169519106 @default.
• W2117764603 cites W2174791196 @default.
• W2117764603 cites W2413398201 @default.
• W2117764603 cites W4244120980 @default.
• W2117764603 cites W4252206428 @default.
• W2117764603 doi "https://doi.org/10.1158/1078-0432.ccr-07-0574" @default.
• W2117764603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17785573" @default.
• W2117764603 hasPublicationYear "2007" @default.
• W2117764603 type Work @default.
• W2117764603 sameAs 2117764603 @default.
• W2117764603 citedByCount "36" @default.
• W2117764603 countsByYear W21177646032012 @default.
• W2117764603 countsByYear W21177646032013 @default.
• W2117764603 countsByYear W21177646032014 @default.
• W2117764603 countsByYear W21177646032015 @default.
• W2117764603 countsByYear W21177646032016 @default.
• W2117764603 countsByYear W21177646032017 @default.
• W2117764603 countsByYear W21177646032018 @default.
• W2117764603 countsByYear W21177646032019 @default.
• W2117764603 countsByYear W21177646032020 @default.
• W2117764603 countsByYear W21177646032022 @default.
• W2117764603 countsByYear W21177646032023 @default.
• W2117764603 crossrefType "journal-article" @default.
• W2117764603 hasAuthorship W2117764603A5011803647 @default.
• W2117764603 hasAuthorship W2117764603A5046035975 @default.
• W2117764603 hasAuthorship W2117764603A5047145712 @default.
• W2117764603 hasAuthorship W2117764603A5085434984 @default.
• W2117764603 hasAuthorship W2117764603A5086797250 @default.
• W2117764603 hasConcept C121608353 @default.
• W2117764603 hasConcept C126322002 @default.
• W2117764603 hasConcept C134018914 @default.
• W2117764603 hasConcept C170493617 @default.
• W2117764603 hasConcept C2776362946 @default.
• W2117764603 hasConcept C2777506169 @default.
• W2117764603 hasConcept C2778820342 @default.
• W2117764603 hasConcept C2779281246 @default.
• W2117764603 hasConcept C2779438470 @default.
• W2117764603 hasConcept C2780512811 @default.
• W2117764603 hasConcept C2780580887 @default.
• W2117764603 hasConcept C2781172350 @default.
• W2117764603 hasConcept C2781219945 @default.
• W2117764603 hasConcept C42362537 @default.
• W2117764603 hasConcept C55493867 @default.
• W2117764603 hasConcept C71924100 @default.
• W2117764603 hasConcept C86803240 @default.
• W2117764603 hasConceptScore W2117764603C121608353 @default.
• W2117764603 hasConceptScore W2117764603C126322002 @default.
• W2117764603 hasConceptScore W2117764603C134018914 @default.

• next